lifestyle.cfxmagazine.com

Author: Tevogen Bio Inc

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

March 26, 2026
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

March 25, 2026
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)

March 18, 2026
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

March 13, 2026
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

March 13, 2026
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

March 11, 2026
Tevogen Names Leadership Team to Execute Diversified Growth Strategy

March 9, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi

March 6, 2026
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

March 5, 2026
Tevogen Announces Reverse Stock Split

March 4, 2026